The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2023

Filed:

May. 18, 2022
Applicant:

Mpeg La, L.l.c., Chevy Chase, MD (US);

Inventors:

Philipp Hadwiger, Kulmbach, DE;

Hans-Peter Vornlocher, Kulmbach, DE;

Jonathan Miles Brown, Silver Spring, MD (US);

James Everett Dahlman, Atlanta, GA (US);

Kristin K. H. Neuman, Larchmont, NY (US);

Assignee:

MPEG LA, LLC, Chevy Chase, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/115 (2010.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 9/127 (2006.01); A61K 47/54 (2017.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
C12N 15/115 (2013.01); A61K 9/127 (2013.01); A61K 47/549 (2017.08); A61K 47/6911 (2017.08); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 2310/14 (2013.01); C12N 2310/315 (2013.01); C12N 2310/317 (2013.01); C12N 2310/321 (2013.01); C12N 2310/322 (2013.01); C12N 2310/346 (2013.01); C12N 2310/351 (2013.01); C12N 2310/3521 (2013.01); C12N 2310/3533 (2013.01); C12N 2310/51 (2013.01);
Abstract

Defined multi-conjugate oligonucleotides can have predetermined sizes and compositions. For example, in various embodiment, defined multi-conjugate oligonucleotides can have advantageous properties, for example in the form of defined multi-conjugate siRNA (i.e., including two, three or more siRNA) having enhanced intracellular delivery and/or multi-gene silencing effects. In various embodiment, the defined multi-conjugate oligonucleotides can be synthesized via new synthetic intermediates and methods. The defined multi-conjugate oligonucleotides can be used, for example, in reducing gene expression, biological research, treating or preventing medical conditions, or to produce new or altered phenotypes in cells or organisms.


Find Patent Forward Citations

Loading…